Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCranswick Regulatory News (CWK)

Share Price Information for Cranswick (CWK)

Share Price is delayed by 15 minutes
Get Live Data
5,670.00    20.00 (0.35%)
Bid:
5,670.00
Ask:
5,690.00
Spread: 20.00 (0.353%)
Market Cap: £3.04b
CWK Live PriceLast checked at - London Stock Exchange

Intraday Cranswick Share Chart

Half Year Trading Update

27 Sep 2024 07:00

RNS Number : 8990F
Cranswick PLC
27 September 2024
 

27 September 2024

 

Cranswick plc

("Cranswick" or "the Company" or "the Group")

 

 

Half year trading update

 

Cranswick, a leading UK food producer, today provides an update on trading for the 26 weeks to 28 September 2024.

 

Current trading

Trading since the end of the first quarter has been stronger than previously expected, underpinned by continued robust volume growth in our core UK food business, a positive ongoing contribution from our expanding pig farming operations, industry leading service levels and a relentless focus on quality and innovation. Consequently, we now expect our first half performance to be ahead of the same period last year.

 

Investment in our asset base continues at pace with the new houmous facility in Worsley, Manchester successfully commissioned during the period.

 

Outlook

Whilst we remain cautious about current market and wider economic and geopolitical conditions, following the strong volume growth delivered through the first half, our outlook for the current financial year ending 29 March 2025 is now expected to be towards the upper end of current market expectations1.

 

The Board remains confident that continued focus on the strengths of the Company, which include its long-standing customer relationships, breadth and quality of products and industry leading asset infrastructure, will support the further successful development of the Group over the longer term.

 

Interim results

The Company's next scheduled comment on trading will be the interim results announcement on Tuesday 26 November 2024.

 

 

Enquiries:

 

Cranswick plc

01482 275 000

Mark Bottomley, Chief Financial Officer

Sodali & Co

+44 207 100 6451

Ben Foster / Louisa Henry

cranswick@sodali.com

 

Notes:

 

1. Market expectations for adjusted profit before tax as at 27 September 2024 ranged between £179.2m and £191.7m.

2. Cranswick is a leading and innovative supplier of premium, fresh and added-value food products. The business employs over 15,000 people and operates from 23 well-invested, highly efficient production facilities in the UK. Cranswick was formed in the early 1970s by farmers in East Yorkshire to produce animal feed and has since evolved into a business which produces a range of high quality, predominantly fresh food, including fresh pork, poultry, convenience, gourmet products and pet food. The business develops innovative, great tasting food products to the highest standards of food safety and traceability. The Group supplies the major grocery multiples as well as the growing premium and discounter retail channels. Cranswick also has a strong presence in the 'food-to-go' sector and a substantial export business. Results for the 53 weeks to 30 March 2024 showed revenue of £2,599.3m and profit before tax of £158.4m. For more information go to: www.cranswick.plc.uk

3. At Cranswick, it is second nature for us to protect and nurture our environment while supporting people and communities to thrive. Guided by our sustainability strategy, Second Nature, we have seamlessly integrated our sustainability commitments into the core of our business model, which in turn shapes our decision-making, culture, and actions. For more information on out Second Nature strategy, please visit: www.cranswick.plc.uk/sustainability

4. This announcement is based on information sourced from unaudited management accounts.

5. This announcement contains certain forward looking statements. By their nature, forward looking statements involve a number of risks, uncertainties or assumptions that could cause actual results or events to differ materially from those expressed or implied by those statements. Forward looking statements regarding past trends or activities should not be taken as representation that such trends or activities will continue in the future. Accordingly undue reliance should not be placed on forward looking statements.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGZLLVLGDZM
Date   Source Headline
3rd Jun 20263:37 pmRNSDirector/PDMR Shareholding
1st Jun 20268:41 amRNSTotal Voting Rights
26th May 202610:27 amRNSDirector/PDMR Shareholding
22nd May 20263:39 pmRNSDirector/PDMR Shareholding
21st May 20263:27 pmRNSDirectors Dealing
19th May 20267:00 amRNSPreliminary Results
13th May 202611:03 amRNSIssue of Equity/Admission to Trading
1st May 202611:53 amRNSTotal Voting Rights
22nd Apr 20266:05 pmRNSDirector/PDMR Shareholding
1st Apr 20263:44 pmRNSTotal Voting Rights
31st Mar 202612:33 pmRNSIssue of Equity/Admission to Trading
25th Mar 20267:00 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
24th Mar 202610:37 amRNSDirector/PDMR Shareholding
23rd Mar 202610:31 amRNSDirector/PDMR Shareholding
12th Mar 202612:07 pmRNSHolding(s) in Company
10th Mar 20264:47 pmRNSHolding(s) in Company
4th Mar 20265:17 pmRNSHolding(s) in Company
2nd Mar 20263:24 pmRNSHolding(s) in Company
2nd Mar 20263:21 pmRNSTotal Voting Rights
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:21 pmRNSDirector/PDMR Shareholding
2nd Mar 20263:18 pmRNSDirector/PDMR Shareholding
26th Feb 20263:55 pmRNSHolding(s) in Company
24th Feb 202611:31 amRNSDirector/PDMR Shareholding
18th Feb 20265:55 pmRNSHolding(s) in Company
18th Feb 202612:11 pmRNSHolding(s) in Company
2nd Feb 20263:54 pmRNSTotal Voting Rights
30th Jan 20266:10 pmRNSHolding(s) in Company
30th Jan 20267:00 amRNSHolding(s) in Company
28th Jan 20265:59 pmRNSHolding(s) in Company
27th Jan 20267:00 amRNSThird quarter trading statement
23rd Jan 202611:27 amRNSDirector/PDMR Shareholding
22nd Jan 20264:51 pmRNSHolding(s) in Company
22nd Jan 20263:17 pmRNSHolding(s) in Company
19th Jan 20267:00 amRNSHolding(s) in Company
5th Jan 202610:52 amRNSTotal Voting Rights
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 202512:48 pmRNSDirector/PDMR Shareholding
23rd Dec 20257:00 amRNSHolding(s) in Company
23rd Dec 20257:00 amRNSHolding(s) in Company
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
22nd Dec 202511:33 amRNSDirector/PDMR Shareholding
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20253:18 pmRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
5th Dec 20259:15 amRNSHolding(s) in Company
1st Dec 202510:49 amRNSTotal Voting Rights
25th Nov 20257:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.